Allergic inflammation and Transcriptional Regulation in Th9 cells
过敏性炎症和 Th9 细胞的转录调控
基本信息
- 批准号:10521266
- 负责人:
- 金额:$ 56.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-15 至 2025-10-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAcuteAllergensAllergicAllergic DiseaseAllergic inflammationAnaphylaxisAspergillus fumigatusAsthmaAttenuatedCD4 Positive T LymphocytesCell Differentiation processCell physiologyCellsChronicChronic DiseaseClinical TrialsCommunicationCost of IllnessDataDevelopmentDisease modelEffector CellEnvironmentEyeFood HypersensitivityFundingGene ExpressionGenetic TranscriptionGoalsGrantHealthHealth Care CostsHelper-Inducer T-LymphocyteHematopoieticHypersensitivityIL9 geneIRF4 geneImmune responseIn VitroInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInterleukin-13Interleukin-4Interleukin-9LungLymphoid CellMaintenanceMediatingMemoryModelingMutant Strains MiceOrganPathogenicityPatientsPhenotypePopulationProductionProductivityRegulationRegulatory ElementRestRoleSourceStructure of parenchyma of lungSymptomsSystemT cell responseT memory cellT-LymphocyteTestingTh2 CellsTissuesTranscriptional RegulationTumor ImmunityUlcerative ColitisUnited Statesallergic airway diseasecell typeconditional mutantcytokinehuman modelin vivomouse modelresponseseasonal allergiessingle-cell RNA sequencingtooltranscription factortranscriptome
项目摘要
PROJECT SUMMARY – Regulation of Allergic inflammation by IL-9-secreting T cells
Interleukin-9 (IL-9) is a pleuripotent cytokine that leads to altered gene expression and cellular function in
hematopoietic and structural cell populations. IL-9 is most efficiently produced by innate lymphoid cells, and a
specialized subset of T helper cells termed Th9 cells. Importantly, IL-9 has a role, in both humans and mouse
models, in asthma, food allergy, ulcerative colitis, and anti-tumor immunity. In the previous funding period of
this grant we have made considerable progress in understanding the regulation of the Il9 gene and the
transcription factors that are involved in controlling Il9 gene expression. As we defined systems for best
analyzing IL-9-secreting T cells in vivo, we observed that in a model of chronic allergen exposure, IL-9-
producing CD4+ T cells were in the tissue resident memory (Trm) population. We further observed that the IL-
9-secreting Trm population was stable in the absence of allergen exposure and was instrumental in mediating
the inflammatory response to allergen challenge after a period of ‘rest’ from allergen exposure. Blocking IL-9
during this post-rest challenge significantly diminished the inflammatory response. In this renewal application,
we will define the identity of the IL-9-secreting T cells, determine the transcription factors that are required for
their development, and identify the cytokines that are important for their development, maintenance, and
effector function. As the CD4+ Trm population in allergic inflammation has not been characterized and this
population is likely important in the context of intermittent allergen exposure as occurs in seasonal allergies,
the proposed studies could have a foundational impact on understanding how CD4+ Trm impact allergic
disease.
项目摘要 - 通过分泌IL-9的T细胞来调节过敏性炎症
白介素-9(IL-9)是一种胸膜细胞因子,导致基因表达和细胞功能改变
造血和结构细胞种群。 IL-9最有效地由先天淋巴样细胞产生,A
T辅助细胞的专门子集称为Th9细胞。重要的是,IL-9在人类和小鼠中都有作用
模型,哮喘,食物过敏,溃疡性结肠炎和抗肿瘤免疫。在上一个资金期
我们在理解IL9基因的调节和
控制IL9基因表达的转录因子。当我们定义最佳系统时
分析了分析IL-9分泌T细胞的体内,我们观察到,在慢性过敏原暴露模型中,IL-9--
产生CD4+ T细胞在组织居民记忆(TRM)中。我们进一步观察到IL-
在没有过敏原暴露的情况下,9分泌的TRM种群是稳定的,并且有助于介导
过敏原暴露的“休息”一段时间后,对过敏原挑战的炎症反应。阻止IL-9
在此后期,挑战大大减少了炎症反应。在此续签应用中,
我们将定义分泌IL-9分泌T细胞的身份,确定转录因子
它们的开发,并确定对它们的开发,维护以及
效应子功能。由于过敏注射中的CD4+ TRM种群尚未表征,因此
在季节性过敏中发生的间歇过敏原暴露的情况下,人口可能很重要
提出的研究可能对了解CD4+ TRM如何影响过敏有基本的影响
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK H KAPLAN其他文献
MARK H KAPLAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK H KAPLAN', 18)}}的其他基金
IL-9-dependent interstitial macrophage function in the allergic lung
过敏性肺中 IL-9 依赖性间质巨噬细胞功能
- 批准号:
10741356 - 财政年份:2017
- 资助金额:
$ 56.49万 - 项目类别:
Granzyme A-secreting T cells in allergic inflammation
过敏性炎症中粒酶 A 分泌 T 细胞
- 批准号:
8869766 - 财政年份:2015
- 资助金额:
$ 56.49万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
EXposomic Profiling in Airway disease to uNravel Determinants of disease in Asthma (EXPAND-Asthma) Center
气道疾病暴露组分析以解开哮喘疾病的决定因素 (EXPAND-Asthma) 中心
- 批准号:
10744673 - 财政年份:2023
- 资助金额:
$ 56.49万 - 项目类别:
Chitin and chitinases in SARS-CoV-2 infection
SARS-CoV-2 感染中的几丁质和几丁质酶
- 批准号:
10742004 - 财政年份:2023
- 资助金额:
$ 56.49万 - 项目类别:
An immunotherapeutic IgY formulation against norovirus diarrhea
一种针对诺如病毒腹泻的免疫治疗 IgY 制剂
- 批准号:
10693530 - 财政年份:2023
- 资助金额:
$ 56.49万 - 项目类别:
Mast cell regulation of food allergen induced malaise through GDF15-GFRAL signaling
肥大细胞通过 GDF15-GFRAL 信号调节食物过敏原引起的不适
- 批准号:
10605915 - 财政年份:2023
- 资助金额:
$ 56.49万 - 项目类别:
Prostaglandin D2 and its receptor CRTH2 regulate intestinal inflammation and homeostasis
前列腺素 D2 及其受体 CRTH2 调节肠道炎症和体内平衡
- 批准号:
10733671 - 财政年份:2023
- 资助金额:
$ 56.49万 - 项目类别: